Human B immunoglobuline (HBIG) monotherapy or combined with lamivudine (LAM) in prophylaxis of HBV recurrence after liver transplantation (LT) in HBsAg-carriers

被引：0
|
作者：
Gaia, S [1 ]
Marzano, A [1 ]
Ciardo, V [1 ]
Gentilcore, E [1 ]
Lagget, M [1 ]
Smedile, A [1 ]
Rizzetto, M [1 ]
机构：
[1] Molinette Mauriziano Hosp, Dept Gastroenterol, Turin, Italy
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80111-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
112
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [41] EARLY INTRODUCTION OF SUBCUTANEOUS (SC) HEPATITIS B IMMUNOGLOBULIN (HBIg) PROVIDES EFFECTIVE PROPHYLAXIS FOR HEPATITIS B VIRUS (HBV) REINFECTION AFTER LIVER TRANSPLANTATION (TX)
    Samuel, D.
    De Simone, P.
    Salizoni, M.
    Pinna, A. D.
    Cillo, U.
    Zamboni, F.
    Mutimer, D.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S273 - S273
  • [42] Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: Long-term results
    Dumortier, J
    Chevallier, P
    Scoazec, JY
    Berger, F
    Boillot, O
    AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (08) : 999 - 1002
  • [43] LIVER-TRANSPLANTATION IN HBS-ANTIGEN (HBSAG) CARRIERS - PREVENTION OF HEPATITIS-B VIRUS (HBV) RECURRENCE BY PASSIVE-IMMUNIZATION
    MULLER, R
    GUBERNATIS, G
    FARLE, M
    NIEHOFF, G
    KLEIN, H
    WITTEKIND, C
    TUSCH, G
    LAUTZ, HU
    BOKER, K
    STANGEL, W
    PICHLMAYR, R
    JOURNAL OF HEPATOLOGY, 1991, 13 (01) : 90 - 96
  • [44] RECURRENT HEPATITIS-B VIRUS (HBV) INFECTION IN PATIENTS RECEIVING HEPATITIS-B IMMUNOGLOBULIN (HBIG) PROPHYLAXIS AFTER LIVER-TRANSPLANTATION (LT) - PREDICTIVE VALUE OF CIRCULATING HBV DNA BY POLYMERASE CHAIN-REACTION (PCR)
    VILLAMIL, FG
    KUHNS, MC
    MCNAMARA, AL
    WOOLF, GM
    HOFFMAN, AL
    MAKOWKA, L
    VIERLING, JM
    HEPATOLOGY, 1994, 20 (04) : A129 - A129
  • [45] EARLY INTRODUCTION OF SUBCUTANEOUS (SC) HEPATITIS B IMMUNOGLOBULIN (HBIG) PROVIDES EFFECTIVE PROPHYLAXIS FOR HEPATITIS B VIRUS (HBV) REINFECTION AFTER LIVER TRANSPLANTATION (TX)
    Roche, B.
    Zoulim, F.
    De Simone, P.
    Samuel, D.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 21 - 21
  • [46] Intramuscular hepatitis B immune globulin combined with Lamivudine prevents low-level HBV DNA after liver transplantation
    Choi, J. -Y.
    Bae, S. -H.
    Yoon, S. -K.
    Kim, D. -G.
    LIVER INTERNATIONAL, 2006, 26 : 13 - 13
  • [47] Lamivudine (LAM) treatment for hepatitis B virus (HBV) infected patients undergoing liver transplantation (LT): Monitoring response with a quantitative polymerase chain reaction (QPCR) assay.
    Mutimer, D
    Tang, H
    Dragon, B
    Gutekunst, K
    Barmat, S
    Ahmed, M
    ODonnell, K
    Shaw, J
    Elias, E
    GASTROENTEROLOGY, 1997, 112 (04) : A1342 - A1342
  • [48] Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation
    Ferretti, G
    Merli, M
    Corradini, SG
    Callejon, V
    Tanzilli, P
    Masini, A
    Ferretti, S
    Iappelli, M
    Rossi, M
    Rivanera, D
    Lilli, D
    Mancini, C
    Attili, A
    Berloco, P
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (03) : 535 - 538
  • [49] Efficacy of lamivudine re-treatment in a patient with hepatitis B virus (HBV) recurrence after liver transplantation and HBV-DNA breakthrough during the first treatment
    Marzano, A
    Debernardi-Venon, W
    Condreay, L
    Rizzetto, M
    TRANSPLANTATION, 1998, 65 (11) : 1499 - 1500
  • [50] It's HBV DNA but no HBV cccDNA persist in immunocytes, CD34+ cells after liver transplantation undergoing prophylaxis combine lamivudine and hepatitis B immunoglobulin.
    Lu, Shi-Chun
    Lai, Wei
    Li, You-Ping
    Zhao, Ji
    Dai, Jun
    Jin, Sheng-Jie
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 373 - 374
12345